<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35631077</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>08</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">556</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens11050556</ELocationID><Abstract><AbstractText>The novel coronavirus SARS-CoV-2, which has similarities to the 2002-2003 severe acute respiratory syndrome coronavirus known as SARS-CoV-1, causes the infectious disease designated COVID-19 by the World Health Organization (Coronavirus Disease 2019). Although the first reports indicated that activity of the virus is centered in the lungs, it was soon acknowledged that SARS-CoV-2 causes a multisystem disease. Indeed, this new pathogen causes a variety of syndromes, including asymptomatic disease; mild disease; moderate disease; a severe form that requires hospitalization, intensive care, and mechanical ventilation; multisystem inflammatory disease; and a condition called long COVID or postacute sequelae of SARS-CoV-2 infection. Some of these syndromes resemble previously described disorders, including those with no confirmed etiology, such as Kawasaki disease. After recognition of a distinct multisystem inflammatory syndrome in children, followed by a similar syndrome in adults, various multisystem syndromes occurring during the pandemic associated or related to SARS-CoV-2 began to be identified. A typical pattern of cytokine and chemokine dysregulation occurs in these complex syndromes; however, the disorders have distinct immunological determinants that may help to differentiate them. This review discusses the origins of the different trajectories of the inflammatory syndromes related to SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>P&#xe9;rez-G&#xf3;mez</LastName><ForeName>H&#xe9;ctor Ra&#xfa;l</ForeName><Initials>HR</Initials><Identifier Source="ORCID">0000-0003-2126-119X</Identifier><AffiliationInfo><Affiliation>Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Patolog&#xed;a Infecciosa y Experimental, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morf&#xed;n-Otero</LastName><ForeName>Rayo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Patolog&#xed;a Infecciosa y Experimental, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-D&#xed;az</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9743-3739</Identifier><AffiliationInfo><Affiliation>Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Patolog&#xed;a Infecciosa y Experimental, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Civil de Guadalajara, Fray Antonio Alcalde, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esparza-Ahumada</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Patolog&#xed;a Infecciosa y Experimental, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Civil de Guadalajara, Fray Antonio Alcalde, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-Garnica</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Patolog&#xed;a Infecciosa y Experimental, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Civil de Guadalajara, Fray Antonio Alcalde, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Noriega</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Patolog&#xed;a Infecciosa y Experimental, Centro Universitario Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MIS-A</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">chemokine abnormalities</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">cytokine</Keyword><Keyword MajorTopicYN="N">multisystem inflammatory syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35631077</ArticleId><ArticleId IdType="pmc">PMC9143280</ArticleId><ArticleId IdType="doi">10.3390/pathogens11050556</ArticleId><ArticleId IdType="pii">pathogens11050556</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley B.T., Maioli H., Johnston R., Chaudhry I., Fink S.L., Xu H., Najafian B., Deutsch G., Lacy J.M., Williams T., et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: A case series. Lancet. 2020;396:320&#x2013;332. doi: 10.1016/S0140-6736(20)31305-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31305-2</ArticleId><ArticleId IdType="pmc">PMC7365650</ArticleId><ArticleId IdType="pubmed">32682491</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao F., Ma Q., Yue Q., Chen H. SARS-CoV-2 Infection and Lung Regeneration. Clin. Microbiol. Rev. 2022;35:e0018821. doi: 10.1128/cmr.00188-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.00188-21</ArticleId><ArticleId IdType="pmc">PMC8809385</ArticleId><ArticleId IdType="pubmed">35107300</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181&#x2013;192. doi: 10.1038/s41579-018-0118-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0118-9</ArticleId><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>Killerby M.E., Biggs H.M., Haynes A., Dahl R.M., Mustaquim D., Gerber S.I., Watson J.T. Human coronavirus circulation in the United States 2014-2017. J. Clin. Virol. 2018;101:52&#x2013;56. doi: 10.1016/j.jcv.2018.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.019</ArticleId><ArticleId IdType="pmc">PMC7106380</ArticleId><ArticleId IdType="pubmed">29427907</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24:490&#x2013;502. doi: 10.1016/j.tim.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.03.003</ArticleId><ArticleId IdType="pmc">PMC7125511</ArticleId><ArticleId IdType="pubmed">27012512</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang X., Nair H. Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2? J. Infect. Dis. 2020;222:1090&#x2013;1097. doi: 10.1093/infdis/jiaa436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa436</ArticleId><ArticleId IdType="pmc">PMC7454715</ArticleId><ArticleId IdType="pubmed">32691843</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., Ahuja A., Yung M.Y., Leung C.B., To K.F., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003;348:1986&#x2013;1994. doi: 10.1056/NEJMoa030685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa030685</ArticleId><ArticleId IdType="pubmed">12682352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814&#x2013;1820. doi: 10.1056/NEJMoa1211721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211721</ArticleId><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi Y.M., Balkhy H.H., Hayden F.G., Bouchama A., Luke T., Baillie J.K., Al-Omari A., Hajeer A.H., Senga M., Denison M.R., et al. Middle East Respiratory Syndrome. N. Engl. J. Med. 2017;376:584&#x2013;594. doi: 10.1056/NEJMsr1408795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1408795</ArticleId><ArticleId IdType="pmc">PMC5362064</ArticleId><ArticleId IdType="pubmed">28177862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumla A., Hui D.S., Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995&#x2013;1007. doi: 10.1016/S0140-6736(15)60454-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60454-8</ArticleId><ArticleId IdType="pmc">PMC4721578</ArticleId><ArticleId IdType="pubmed">26049252</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi A., Ryoo S.G. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis. Int. J. Infect. Dis. 2016;49:129&#x2013;133. doi: 10.1016/j.ijid.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2016.06.015</ArticleId><ArticleId IdType="pmc">PMC7110556</ArticleId><ArticleId IdType="pubmed">27352628</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Liang W., Jiang M., Guan W., Zhan C., Wang T., Tang C., Sang L., Liu J., Ni Z., et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020;158:97&#x2013;105. doi: 10.1016/j.chest.2020.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.04.010</ArticleId><ArticleId IdType="pmc">PMC7158802</ArticleId><ArticleId IdType="pubmed">32304772</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder G., Rezza G., Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323:1775&#x2013;1776. doi: 10.1001/jama.2020.4683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4683</ArticleId><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q., Ji R., Wang H., Wang Y., Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91&#x2013;95. doi: 10.1016/j.ijid.2020.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.017</ArticleId><ArticleId IdType="pmc">PMC7194638</ArticleId><ArticleId IdType="pubmed">32173574</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., The Northwell COVID-19 Research Consortium Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319&#x2013;1325. doi: 10.1016/S0140-6736(03)13077-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13077-2</ArticleId><ArticleId IdType="pmc">PMC7112372</ArticleId><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H.W., Xu Y.M., Lau A.T.Y. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Rev. Med. Virol. 2020;30:e2122. doi: 10.1002/rmv.2122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2122</ArticleId><ArticleId IdType="pmc">PMC7361198</ArticleId><ArticleId IdType="pubmed">32602627</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Lee K.A., Lochlainn M.N., Varsavsky T., Murray B., Graham M.S., Menni C., Modat M., Bowyer R.C.E., Nguyen L.H., et al. Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app. Sci. Adv. 2021;7:eabd4177. doi: 10.1126/sciadv.abd4177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd4177</ArticleId><ArticleId IdType="pmc">PMC7978420</ArticleId><ArticleId IdType="pubmed">33741586</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelle K., Martin M.A., Antia R., Lopman B., Dean N.E. The changing epidemiology of SARS-CoV-2. Science. 2022;375:1116&#x2013;1121. doi: 10.1126/science.abm4915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm4915</ArticleId><ArticleId IdType="pmc">PMC9009722</ArticleId><ArticleId IdType="pubmed">35271324</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhi S.A., Kwatra G., Myers J.E., Jassat W., Dhar N., Mukendi C.K., Nana A.J., Blumberg L., Welch R., Ngorima-Mabhena N., et al. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa. N. Engl. J. Med. 2022;386:1314&#x2013;1326. doi: 10.1056/NEJMoa2119658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2119658</ArticleId><ArticleId IdType="pmc">PMC8908853</ArticleId><ArticleId IdType="pubmed">35196424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhalala U.S., Gist K.M., Tripathi S., Boman K., Kumar V.K., Retford L., Chiotos K., Blatz A.M., Dapul H., Verma S., et al. Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry. Crit. Care Med. 2022;50:e40&#x2013;e51. doi: 10.1097/CCM.0000000000005232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005232</ArticleId><ArticleId IdType="pmc">PMC8670078</ArticleId><ArticleId IdType="pubmed">34387240</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D.S., Whitaker M., Marks K.J., Anglin O., Milucky J., Patel K., Pham H., Chai S.J., Kawasaki B., Meek J., et al. Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19&#x2014;COVID-NET, 14 States, March 2020-February 2022. Morb. Mortal. Wkly. Rep. 2022;71:574&#x2013;581. doi: 10.15585/mmwr.mm7116e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7116e1</ArticleId><ArticleId IdType="pmc">PMC9042359</ArticleId><ArticleId IdType="pubmed">35446827</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607&#x2013;1608. doi: 10.1016/S0140-6736(20)31094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2. JAMA. 2020;324:259&#x2013;269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P., Evans C., Kanthimathinathan H.K., Lillie J., Brierley J., Waters G., Johnson M., Griffiths B., du Pre P., Mohammad Z., et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: A multicentre observational study. Lancet Child Adolesc. Health. 2020;4:669&#x2013;677. doi: 10.1016/S2352-4642(20)30215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30215-7</ArticleId><ArticleId IdType="pmc">PMC7347350</ArticleId><ArticleId IdType="pubmed">32653054</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020;383:334&#x2013;346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort E.M., Koumans E.H., Chow E.J., Rosenthal E.M., Muse A., Rowlands J., Barranco M.A., Maxted A.M., Rosenberg E.S., Easton D., et al. Multisystem Inflammatory Syndrome in Children in New York State. N. Engl. J. Med. 2020;383:347&#x2013;358. doi: 10.1056/NEJMoa2021756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021756</ArticleId><ArticleId IdType="pmc">PMC7346766</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfred-Cato S., Bryant B., Leung J., Oster M.E., Conklin L., Abrams J., Roguski K., Wallace B., Prezzato E., Koumans E.H., et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children&#x2014;United States, March&#x2013;July 2020. Morb. Mortal. Wkly. Rep. 2020;69:1074&#x2013;1080. doi: 10.15585/mmwr.mm6932e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6932e2</ArticleId><ArticleId IdType="pmc">PMC7440126</ArticleId><ArticleId IdType="pubmed">32790663</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne A.B., Gilani Z., Godfred-Cato S., Belay E.D., Feldstein L.R., Patel M.M., Randolph A.G., Newhams M., Thomas D., Magleby R., et al. Incidence of Multisystem Inflammatory Syndrome in Children among US Persons Infected with SARS-CoV-2. JAMA Netw. Open. 2021;4:e2116420. doi: 10.1001/jamanetworkopen.2021.16420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16420</ArticleId><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z., Meot M., Bajolle F., Khraiche D., Legendre A., Abakka S., Auriau J., Grimaud M., Oualha M., Beghetti M., et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142:429&#x2013;436. doi: 10.1161/CIRCULATIONAHA.120.048360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.048360</ArticleId><ArticleId IdType="pubmed">32418446</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBiasi R.L., Harahsheh A.S., Srinivasalu H., Krishnan A., Sharron M.P., Parikh K., Smith K., Bell M., Michael D., Delaney M., et al. Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing. J. Pediatr. 2021;237:125&#x2013;135.e18. doi: 10.1016/j.jpeds.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2021.06.002</ArticleId><ArticleId IdType="pubmed">34181987</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara D., Chang J., Kauffman H.L., Wang Y., Nadaraj S., Patel C., Paridon S.M., Fogel M.A., Quartermain M.D., Banerjee A. Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Infections. J. Am. Heart Assoc. 2022;11:e023251. doi: 10.1161/JAHA.121.023251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.023251</ArticleId><ArticleId IdType="pmc">PMC9238494</ArticleId><ArticleId IdType="pubmed">35043684</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T., Kosaki F., Okawa S., Shigematsu I., Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271&#x2013;276. doi: 10.1542/peds.54.3.271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.54.3.271</ArticleId><ArticleId IdType="pubmed">4153258</ArticleId></ArticleIdList></Reference><Reference><Citation>Shackelford P.G., Strauss A.W. Kawasaki syndrome. N. Engl. J. Med. 1991;324:1664&#x2013;1666. doi: 10.1056/NEJM199106063242311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199106063242311</ArticleId><ArticleId IdType="pubmed">1709447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T. Kawasaki disease. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2006;82:59&#x2013;71. doi: 10.2183/pjab.82.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.2183/pjab.82.59</ArticleId><ArticleId IdType="pmc">PMC4323050</ArticleId><ArticleId IdType="pubmed">25792773</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M., Baker A.L., Jackson M.A., Takahashi M., Shah P.B., et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135:e927&#x2013;e999. doi: 10.1161/CIR.0000000000000484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara H., Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 1978;61:100&#x2013;107. doi: 10.1542/peds.61.1.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.61.1.100</ArticleId><ArticleId IdType="pubmed">263836</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfred-Cato S., Abrams J., Balachandran N., Jaggi P., Jones K., Rostad C., Lu A., Fan L., Jabbar A., Anderson E., et al. Distinguishing Multisystem Inflammatory Syndrome in Children from COVID-19, Kawasaki Disease and Toxic Shock Syndrome. Pediatr. Infect. Dis. J. 2022;41:315&#x2013;323. doi: 10.1097/INF.0000000000003449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003449</ArticleId><ArticleId IdType="pmc">PMC8919949</ArticleId><ArticleId IdType="pubmed">35093995</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRovere K.L., Riggs B.J., Poussaint T.Y., Young C.C., Newhams M.M., Maamari M., Walker T.C., Singh A.R., Dapul H., Hobbs C.V., et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021;78:536&#x2013;547. doi: 10.1001/jamaneurol.2021.0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0504</ArticleId><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Radia T., Williams N., Agrawal P., Harman K., Weale J., Cook J., Gupta A. Multi-system inflammatory syndrome in children &amp; adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr. Respir. Rev. 2021;38:51&#x2013;57. doi: 10.1016/j.prrv.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7417920</ArticleId><ArticleId IdType="pubmed">32891582</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Yin L., Patel J., Tang L., Huang Y. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis. J. Med. Virol. 2021;93:4358&#x2013;4369. doi: 10.1002/jmv.26951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26951</ArticleId><ArticleId IdType="pmc">PMC8250955</ArticleId><ArticleId IdType="pubmed">33739452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M., Advani S., Moreira A., Zoretic S., Martinez J., Chorath K., Acosta S., Naqvi R., Burmeister-Morton F., Burmeister F., et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020;26:100527. doi: 10.1016/j.eclinm.2020.100527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100527</ArticleId><ArticleId IdType="pmc">PMC7473262</ArticleId><ArticleId IdType="pubmed">32923992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano L.D., Newhams M.M., Olson S.M., Halasa N.B., Price A.M., Boom J.A., Sahni L.C., Kamidani S., Tarquinio K.M., Maddux A.B., et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years&#x2014;United States, July-December 2021. Morb. Mortal. Wkly. Rep. 2022;71:52&#x2013;58. doi: 10.15585/mmwr.mm7102e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e1</ArticleId><ArticleId IdType="pmc">PMC8757620</ArticleId><ArticleId IdType="pubmed">35025852</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaigany S., Gnirke M., Guttmann A., Chong H., Meehan S., Raabe V., Louie E., Solitar B., Femia A. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19. Lancet. 2020;396:e8&#x2013;e10. doi: 10.1016/S0140-6736(20)31526-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31526-9</ArticleId><ArticleId IdType="pmc">PMC7351414</ArticleId><ArticleId IdType="pubmed">32659211</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris S.B., Schwartz N.G., Patel P., Abbo L., Beauchamps L., Balan S., Lee E.H., Paneth-Pollak R., Geevarughese A., Lash M.K., et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection&#x2014;United Kingdom and United States, March&#x2013;August 2020. Morb. Mortal. Wkly. Rep. 2020;69:1450&#x2013;1456. doi: 10.15585/mmwr.mm6940e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6940e1</ArticleId><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Davogustto G.E., Clark D.E., Hardison E., Yanis A.H., Lowery B.D., Halasa N.B., Wells Q.S. Characteristics Associated with Multisystem Inflammatory Syndrome among Adults with SARS-CoV-2 Infection. JAMA Netw. Open. 2021;4:e2110323. doi: 10.1001/jamanetworkopen.2021.10323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.10323</ArticleId><ArticleId IdType="pmc">PMC8134998</ArticleId><ArticleId IdType="pubmed">34009351</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P., DeCuir J., Abrams J., Campbell A.P., Godfred-Cato S., Belay E.D. Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review. JAMA Netw. Open. 2021;4:e2126456. doi: 10.1001/jamanetworkopen.2021.26456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.26456</ArticleId><ArticleId IdType="pmc">PMC8459192</ArticleId><ArticleId IdType="pubmed">34550381</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay E.D., Godfred Cato S., Rao A.K., Abrams J., Wilson W.W., Lim S., Newton-Cheh C., Melgar M., DeCuir J., Webb B., et al. Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination. Clin. Infect. Dis. 2021:ciab936. doi: 10.1093/cid/ciab936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab936</ArticleId><ArticleId IdType="pmc">PMC8690151</ArticleId><ArticleId IdType="pubmed">34849680</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzman M.B., Huang C.W., O&#x2019;Brien C.M., Castillo R.D. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination. Emerg. Infect. Dis. 2021;27:1944&#x2013;1948. doi: 10.3201/eid2707.210594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2707.210594</ArticleId><ArticleId IdType="pmc">PMC8237872</ArticleId><ArticleId IdType="pubmed">34034858</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune A., Iyengar K.P., Goddard C., Ahmed A.E. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V) BMJ Case Rep. 2021;14:e243888. doi: 10.1136/bcr-2021-243888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-243888</ArticleId><ArticleId IdType="pmc">PMC8323360</ArticleId><ArticleId IdType="pubmed">34326117</ArticleId></ArticleIdList></Reference><Reference><Citation>Grome H.N., Threlkeld M., Threlkeld S., Newman C., Martines R.B., Reagan-Steiner S., Whitt M.A., Gomes-Solecki M., Nair N., Fill M.M., et al. Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination. Emerg. Infect. Dis. 2021;27:2914&#x2013;2918. doi: 10.3201/eid2711.211612.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2711.211612</ArticleId><ArticleId IdType="pmc">PMC8544993</ArticleId><ArticleId IdType="pubmed">34586059</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalcinkaya R., Oz F.N., Polat M., Ucan B., Teke T.A., Kaman A., Ozdem S., Savas Sen Z., Cinni R.G., Tanir G. A Case of Multisystem Inflammatory Syndrome in a 12-year-old Male after COVID-19 mRNA Vaccine. Pediatr. Infect. Dis. J. 2021;41:e87&#x2013;e89. doi: 10.1097/INF.0000000000003432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003432</ArticleId><ArticleId IdType="pmc">PMC8828314</ArticleId><ArticleId IdType="pubmed">34978781</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchhorn R., Meyer C., Schulze-Forster K., Junker J., Heidecke H. Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? Vaccines. 2021;9:1353. doi: 10.3390/vaccines9111353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9111353</ArticleId><ArticleId IdType="pmc">PMC8618727</ArticleId><ArticleId IdType="pubmed">34835284</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: Retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., et al. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick J.L., Titus A.R., Slocum E., Power L.E., Hirschtick R.E., Elliott M.R., McKane P., Fleischer N.L. Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics. Clin. Infect. Dis. 2021;73:2055&#x2013;2064. doi: 10.1093/cid/ciab408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab408</ArticleId><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mule G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2021;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., Ernst K.C., Jacobs E.T., Klimentidis Y.C., Jehn M., Pogreba-Brown K. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS ONE. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>LaVergne S.M., Stromberg S., Baxter B.A., Webb T.L., Dutt T.S., Berry K., Tipton M., Haberman J., Massey B.R., McFann K., et al. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect. Dis. 2021;21:677. doi: 10.1186/s12879-021-06359-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06359-2</ArticleId><ArticleId IdType="pmc">PMC8276222</ArticleId><ArticleId IdType="pubmed">34256735</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.E., Dendy J.M., Li D.L., Crum K., Dixon D., George-Durrett K., Parikh A.P., Wassenaar J.W., Hughes S.G., Soslow J.H. Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: A case-control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC) J. Cardiovasc. Magn. Reson. 2021;23:106. doi: 10.1186/s12968-021-00798-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00798-1</ArticleId><ArticleId IdType="pmc">PMC8495668</ArticleId><ArticleId IdType="pubmed">34620179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn R., Berg S., Berntson L., Berthold E., Brodin P., Backstrom F., Compagno M., Fasth A., Lingman Framme J., Horne A., et al. Population-based study of multisystem inflammatory syndrome associated with COVID-19 found that 36% of children had persistent symptoms. Acta Paediatr. 2022;111:354&#x2013;362. doi: 10.1111/apa.16191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16191</ArticleId><ArticleId IdType="pmc">PMC9011862</ArticleId><ArticleId IdType="pubmed">34806789</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell. Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2021;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Twohig K.A., Nyberg T., Zaidi A., Thelwall S., Sinnathamby M.A., Aliabadi S., Seaman S.R., Harris R.J., Hope R., Lopez-Bernal J., et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study. Lancet Infect. Dis. 2022;22:35&#x2013;42. doi: 10.1016/S1473-3099(21)00475-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00475-8</ArticleId><ArticleId IdType="pmc">PMC8397301</ArticleId><ArticleId IdType="pubmed">34461056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart W.S., Miller E., Andrew N.J., Waight P., Maini P.K., Funk S., Thompson R.N. Generation time of the alpha and delta SARS-CoV-2 variants: An epidemiological analysis. Lancet Infect. Dis. 2022;22:603&#x2013;610. doi: 10.1016/S1473-3099(22)00001-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00001-9</ArticleId><ArticleId IdType="pmc">PMC8843191</ArticleId><ArticleId IdType="pubmed">35176230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T., Wang L., Misasi J., Pegu A., Zhang Y., Harris D.R., Olia A.S., Talana C.A., Yang E.S., Chen M., et al. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science. 2022;376:eabn8897. doi: 10.1126/science.abn8897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn8897</ArticleId><ArticleId IdType="pmc">PMC9580340</ArticleId><ArticleId IdType="pubmed">35324257</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Polidori L., Antonelli M., Penamakuri S., Nogal A., Louca P., May A., Figueiredo J.C., Hu C., et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study. Lancet. 2022;399:1618&#x2013;1624. doi: 10.1016/S0140-6736(22)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;jiac136 doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., McCann K., O&#x2019;Brien C., Savinelli S., Tinago W., Yousif O., Lambert J.S., O&#x2019;Broin C., Feeney E.R., De Barra E., et al. Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open Forum Infect. Dis. 2022;9:ofac060. doi: 10.1093/ofid/ofac060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.H., Chen Y., Wang Q.H., Wang L.R., Jiang L., Yang Y., Chen X., Li Y., Cen Y., Xu C., et al. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 2022:e220461. doi: 10.1001/jamaneurol.2022.0461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu A.C., Carton T.W., Saydah S., Azziz-Baumgartner E., Boehmer T.K., Garret N.Y., Bailey L.C., Cowell L.G., Draper C., Mayer K.H., et al. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2. JAMA Netw. Open. 2022;5:e2147053. doi: 10.1001/jamanetworkopen.2021.47053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.47053</ArticleId><ArticleId IdType="pmc">PMC8817203</ArticleId><ArticleId IdType="pubmed">35119459</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.M., Diorio C., Goodwin E.C., McNerney K.O., Weirick M.E., Gouma S., Bolton M.J., Arevalo C.P., Chase J., Hicks P., et al. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19) J. Pediatric. Infect. Dis. Soc. 2021;10:669&#x2013;673. doi: 10.1093/jpids/piaa161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa161</ArticleId><ArticleId IdType="pmc">PMC7799010</ArticleId><ArticleId IdType="pubmed">33263756</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen N.A.F., Grondman I., de Nooijer A.H., Boahen C.K., Koeken V., Matzaraki V., Kumar V., He X., Kox M., Koenen H., et al. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J. Infect. Dis. 2021;223:1322&#x2013;1333. doi: 10.1093/infdis/jiab065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab065</ArticleId><ArticleId IdType="pmc">PMC7928798</ArticleId><ArticleId IdType="pubmed">33524124</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E., Sarapultsev A., Solomatina L., Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int. J. Mol. Sci. 2022;23:1716. doi: 10.3390/ijms23031716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira C., Crespo A., Ranjbar S., de Lacerda L.B., Lewandrowski M., Ingber J., Parry B., Ravid S., Clark S., Schrimpf M.R., et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022 doi: 10.1038/s41586-022-04702-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04702-4</ArticleId><ArticleId IdType="pmc">PMC10071495</ArticleId><ArticleId IdType="pubmed">35385861</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Caraffa A., Tete G., Gallenga C.E., Ross R., Kritas S.K., Frydas I., Younes A., Di Emidio P., Ronconi G. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J. Biol. Regul. Homeost. Agents. 2020;34:1629&#x2013;1632. doi: 10.23812/20-2EDIT.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-2EDIT</ArticleId><ArticleId IdType="pubmed">32945158</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricke D.O. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies. Front. Immunol. 2021;12:640093. doi: 10.3389/fimmu.2021.640093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.640093</ArticleId><ArticleId IdType="pmc">PMC7943455</ArticleId><ArticleId IdType="pubmed">33717193</ArticleId></ArticleIdList></Reference><Reference><Citation>McClary-Gutierrez J.S., Mattioli M.C., Marcenac P., Silverman A.I., Boehm A.B., Bibby K., Balliet M., de Los Reyes F.L., 3rd, Gerrity D., Griffith J.F., et al. SARS-CoV-2 Wastewater Surveillance for Public Health Action. Emerg. Infect. Dis. 2021;27:1&#x2013;8. doi: 10.3201/eid2709.210753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2709.210753</ArticleId><ArticleId IdType="pmc">PMC8386792</ArticleId><ArticleId IdType="pubmed">34424162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>